Vistagen Therapeutics 株価情報 (NASDAQ: VTGN)

最新ニュース Vistagen Therapeutics (NASDAQ:VTGN) 株価情報

Vistagen Therapeutics

VistaGen Therapeutics

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Vistagen Therapeutics, Inc. - Common Stock

Vistagen Therapeutics Inc

Trading Ideas

QBTS

D-Wave Quantum Option Alert: 858 Jan 17 $15 Calls Swept Near The Ask At $0.70 With Open Interest Of 7,759; Stock Reference Price $9.28

News

OMEX

Odyssey Marine Exploration Forms Joint Venture With CapLat To Advance Strategic Fertilizer Project In Mexico, Secures $4M Funding, And Extends Debt Maturities To Support Sustainable Agriculture And Empower Farmers

WIIM

GDS shares are trading higher following a Tuesday report suggesting the company is considering an IPO of its data center assets in China.

Bryan Lanza, a former adviser to President-elect <a href="https://www.benzinga.com/topic/donald-trump">Donald Trump</a> and now a lobbyist for the cannabis industry, says the incoming administration may pave the way for significant marijuana policy reforms. However, he cautions that full <a href="https://www.benzinga.com/topic/cannabis-legalization">federal legalization of cannabis</a> is unlikely within the next four years.
In a recent <a href="https://www.youtube.com/watch?v=TNTVkxkO01E">interview</a><a href="https://www.youtube.com/@InsideCultivation"> </a>on the Inside Cultivation podcast, Lanza, who served on Trump's 2016 transition team and worked on his 2024 campaign, discussed what the future could hold for federal cannabis policy under a Trump White House.
"This is the first time that we have a Republican president that has given us a pathway to what he's comfortable with," Lanza said, referring to Trump's unexpected <a href="https://www.benzinga.com/markets/cannabis/24/09/40776937/trump-joins-millions-of-americans-who-support-rescheduling-cannabis-weed-industry-responds-to-fo">cannabis-related remarks</a> during the campaign when he described the moment as a "good opportunity" for the industry to make progress. During his campaign, Trump <a href="https://www.benzinga.com/markets/cannabis/24/09/40774795/trump-says-hell-reschedule-cannabis-if-elected-backs-marijuana-banking-reform-and-floridas-amend">said he'd reschedule cannabis</a>, which would provide access to banking services for marijuana companies and open the doors to scientific research.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/11/41787490/donald-trumps-evolving-stance-on-marijuana-is-cannabis-legalization-finally-on-his-agenda">Donald Trump&#8217;s Evolving Stance On Marijuana: Is Cannabis Legalization Finally On His Agenda?</a>
Lanza predicted that the ongoing process to reschedule cannabis under federal law would likely conclude in early 2025, aligning with Trump's stated support for regulating <a href="https://www.benzinga.com/topic/medical-cannabis">medical marijuana</a>. 
"At the end of the day, when a decision is made, he expects his team to execute. And President Trump has made a decision where he is in this space, and it's incumbent on those who go work for him to know that's what he wants to execute, and they're going to execute," Lanza said.
&#8220;Are there going to be obstacles? There's always obstacles in everything, right?" he said, adding that there are "obviously coalitions that are going to be against this." Lanza mentioned big Pharma as one of them.
Trump's potential support for reforms could influence Congress to act on measures such as banking protections for cannabis businesses. Yet, Lanza remains skeptical about achieving full legalization. "Four years is not long enough to accomplish all the goals we need to do in the cannabis space," he said while suggesting that a unified front is the best way to achieve progress.
&#8220;If you splinter off and you have too many different voices going in too many different directions, I guarantee you that is a recipe for failure—and it is a missed opportunity, because Trump is giving you his roadmap," Lanza said.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/12/42655999/house-ethics-committee-alleges-matt-gaetz-violated-laws-releases-report-on-misconduct">House Ethics Committee Alleges Matt Gaetz Violated Laws, Releases Report On Misconduct</a></li>
</ul>
Photo: Anna Moneymaker/Shutterstock.com

Cannabis

Government

Politics

Legal

Trump Is First 'Republican President' With A Pathway To Cannabis Reform, Says Former Adviser

PG&amp;E's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCG#NYSE">PCG</a>) short percent of float has risen 21.56% since its last report. The company recently reported that it has 39.06 million shares sold short, which is 2.03% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.43 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>PG&amp;E Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735233322_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for PG&amp;E has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing PG&amp;E's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, PG&amp;E's peer group average for short interest as a percentage of float is 2.13%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About PG&E?

KKR's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) short percent of float has risen 3.64% since its last report. The company recently reported that it has 11.55 million shares sold short, which is 1.71% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.04 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>KKR Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735233317_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for KKR has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing KKR's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, KKR's peer group average for short interest as a percentage of float is 3.41%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into KKR's Recent Short Interest

Sony Gr's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) short percent of float has risen 8.33% since its last report. The company recently reported that it has 7.84 million shares sold short, which is 0.13% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.06 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Sony Gr Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735233312_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Sony Gr has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Sony Gr's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Sony Gr's peer group average for short interest as a percentage of float is 4.74%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Sony Group Corporation American Depositary Shares

SONY

Looking Into Sony Gr's Recent Short Interest

LNKS

Linkers Industries Shares Halted To The Downside; Stock Now Down -35.56%

Billionaire investor Stanley Druckenmiller recently made a big investment in Broadcom (AVGO), <a href="https://www.benzinga.com/24/12/42659876/stanley-druckenmiller-pours-funds-into-1-trillion-company-already-trading-up-100?adt_ei=%7B%7Bemail%7D%7D&amp;he=%7B%7Bemail%7D%7D">increasing his stake to 239,980 shares</a>.&nbsp;
That stake, up 35% since September, is worth almost $56 million, one of the largest holdings in Druckenmiller&#8217;s private family fund. Now, Broadcom shares have surged almost 70% recently, so the stock is probably due for a breather.
But Druckenmiller&#8217;s big bet suggests there&#8217;s plenty of upside potential left.
I anticipate some consolidation into January and perhaps even February before the stock makes its next big move. That&#8217;s why the trade to make on Broadcom in the near term is a short iron condor.
Let me show you.
The short iron condor is a combination of a short call spread and a short put spread – a trade that sells premium on both the lower and upper bounds of price under the notion that prices remain rangebound in consolidation of strength.
As a result, the position loses the value we collected for selling it, and we are able to buy it back at a cheaper cost and keep the difference as profit for holding the spreads over time.&nbsp;
Here&#8217;s the trade structure I&#8217;m looking at:
<ul>
<li>Sell to open 1 AVGO 17 Jan 260 calls </li>
<li>Buy to open 1 AVGO 17 Jan 265 calls </li>
<li>Buy to open 1 AVGO 17 Jan 220 puts </li>
<li>Sell to open 1 AVGO 17 Jan 215 puts </li>
</ul>
At this writing, the credit collected is $1.67 and this number represents the total profit for the position.&nbsp;&nbsp;
The reason I chose these particular strikes is because of AVGO&#8217;s support and resistance levels. The relative resistance zone currently sits right around $250, and from here we should consolidate (move around within a range of price for a period of time). The relative support is near $225.
This strategy provides four outcomes to exit the trade:&nbsp;
<ol>
<li>Buy back the iron condor as its value erodes – I like to collect 50% of the original collected premium, in general. </li>
<li>Buy back the iron condor within ten days of expiration, especially if there is no movement in price. </li>
<li>If the prices spike above the short strikes (in this case, above $260 or below $220) for more than 3 days: exit the position, irrespective of where profits sit. </li>
<li>Buy back the iron condor if it moves above your threshold for loss – usually between 35%-50% above the collected premium.</li>
</ol>
<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-holiday-24/?utm_source=WebRD-1227">Last Chance to Save 65% – End-of-Year Sale Ends December 31!</a>
Transform your trading strategy with Benzinga Edge. Get exclusive stock picks, daily trade setups, and real-time alerts. Last chance to save 65%—<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-holiday-24/?utm_source=WebRD-1227">don't miss the End-of-Year Sale before it's gone!</a>
Image via Flickr

Opinion

A Billionaire Set Us Up Perfectly for This Options Trade

Rumble shares are trading higher. The stock may be moving on continued strength after the company, last week, announced it has entered into a definitive agreement for a strategic investment of $775 million from Tether.

Reported Earlier: Mastercard SpendingPulse Says U.S. Retail Sales Excluding Automotive Increased 3.8% YoY From Nov 1 Through Dec 24; U.S. Online Retail Sales In Holiday Season Grew 6.7% YoY, Whereas In-store Sales Increased 2.9%

RGTI

Rigetti Computing shares are trading higher amid continued momentum in quantum stocks.

AAR Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIR#NYSE">AIR</a>) will release earnings results for its second quarter, after the closing bell on <a href="https://www.benzinga.com/quote/air/earnings">Tuesday, Jan. 7, 2025</a>.
Analysts expect the Wood Dale, Illinois-based company to report quarterly earnings at 84 cents per share, up from 81 cents per share in the year-ago period. AAR projects to report revenue of $654.09 million for the recent quarter, compared to $545.4 million a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Dec. 20, AAR announced divestiture of non-core Landing Gear Overhaul business to optimize portfolio.
AAR shares fell 0.1% to trade at $60.87 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/AIR/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>RBC Capital analyst Ken Herbert reiterated an Outperform rating with a price target of $75 on Nov. 4. This analyst has an accuracy rate of 64%.</li>
<li>Benchmark analyst Josh Sullivan reiterated a Buy rating with a price target of $83 on Oct. 4. This analyst has an accuracy rate of 85%.</li>
<li>Stifel analyst Bert Subin maintained a Buy rating and decreased the price target from $86 to $85 on July 19. This analyst has an accuracy rate of 62%.</li>
<li>William Blair analyst Louie DiPalma initiated coverage on the stock with an Outperform rating on Jan. 29. This analyst has an accuracy rate of 72%.</li>
</ul>

Considering buying AIR stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="590" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26110243/image-211-1024x590.png" alt="" class="wp-image-707873" style="width:588px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26110243/image-211-1024x590.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26110243/image-211-300x173.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26110243/image-211-768x443.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26110243/image-211.png 1105w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42684694/top-2-health-care-stocks-you-may-want-to-dump-this-quarter">Top 2 Health Care Stocks You May Want To Dump This Quarter</a></li>
</ul>

Earnings

Price Target

Markets

Analyst Ratings

AAR Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Rumble shares are trading higher. The stock may be moving on continued strength after the company, on Friday, announced it has entered into a definitive agreement for a strategic investment of $775 million from Tether.

Fans of global superstar Beyoncé who missed her Christmas Day NFL halftime performance, or want to relive the moment, are in for a treat. Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) is set to feature one of the standout moments from its <a href="https://www.benzinga.com/general/sports/24/12/42512587/netflix-analyst-say-its-only-investable-media-stock-projects-150-million-nfl-christmas-day-boost">debut NFL game streams.</a>
What Happened: For the first time ever, Netflix <a href="https://www.benzinga.com/24/12/42653325/exclusive-netflix-to-have-merry-christmas-with-nfl-games-will-viewers-tune-in-60-say">streamed two live</a> NFL games on Christmas Day. The games, which are part of a three-year deal, saw Netflix as the exclusive home of the Kansas City Chiefs at Pittsburgh Steelers and Baltimore Ravens at Houston Texans matchups on Wednesday.
Beyoncé <a href="https://about.netflix.com/en/news/beyonce-delivers-epic-gift-of-a-halftime-performance-beyonce-bowl-is-coming">performed </a>a 12-minute set during halftime of the Ravens and Texans game, which took place in her hometown of Houston.
Being labeled the "Beyoncé Bowl" by Netflix, the halftime performance featured the first-ever live performances of songs from the singer's "Cowboy Carter" album.
The performance featured guest appearances by Shaboozey, Post Malone and Beyoncé's daughter Blue Ivy Carter.
Netflix announced that "Beyoncé Bowl" will be released as a standalone special on the streaming platform later this week.
The streaming company did not provide an exact date or additional details on whether the special would just be the halftime performance or include behind-the-scenes or additional footage.
Read Also:<a href="https://www.benzinga.com/general/entertainment/24/12/42563662/streamers-max-paramount-won-november-heres-why-analyst-expects-netflix-amazon-to-win-december"> Streamers Max, Paramount+ Won November: Here&#8217;s Why Analyst Expects Netflix, Amazon To Win December</a>
Why It's Important: Netflix appears poised to leverage the star power of one of the world's most popular singers, featured during halftime of its inaugural Christmas Day NFL games.
Beyoncé previously performed at halftime of Super Bowl XLVII in 2013, a performance that featured her Destiny's Child bandmates Kelly Rowland and Michelle Williams, and in 2016 with Coldplay and Bruno Mars at Super Bowl 50. Both halftime performances rank among the most watched in NFL history. &nbsp;
The singer teased that there is more coming from her next month. An Instagram <a href="https://www.instagram.com/p/DEBPJl1yvvp/">post </a>featured Beyoncé on a horse with an American flag and ends with the screen showing the date of Jan. 14, 2025.
While the teaser post may not be in relation to Netflix, the streaming company has more coming from Beyoncé.
The singer and streamer signed a $60 million <a href="https://variety.com/2019/music/news/beyonce-netflix-deal-1203193729/">deal </a>in 2019, which included "Homecoming," a documentary concert film about the singer's 2018 Coachella performance.
Several reports suggest that the NFL Christmas Day performance and subsequent "Beyoncé Bowl" release are the second of the three projects, leaving one more Netflix special coming from the global superstar.
NFLX Price Action: Netflix stock is down 1.2% to $920.78 on Monday versus a 52-week trading range of $461.86 to $941.75. Netflix stock is up 97% year-to-date in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/sports/24/12/42628116/netflix-adds-womens-world-cup-media-rights-from-football-to-futbol-streamer-all-in-on-live-sports">Netflix Adds Women&#8217;s World Cup Media Rights: From Football To Futbol, Streamer All-In On Live Sports</a></li>
</ul>
Photo: Shutterstock

Entertainment

Sports

NFLX

Netflix To Release 'Beyoncé Bowl' NFL Halftime Performance As Standalone Special

BOOT

DLTR

FIVE

ULTA

Shares of retail stocks are trading higher in possible reaction to Mastercard SpendingPulse data, which showed US retail sales grew 3.8% in the holiday season.

Wedbush analyst Daniel Ives maintains Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) with a Outperform and raises the price target from $300 to $325.

AAPL

Wedbush Maintains Outperform on Apple, Raises Price Target to $325

Macro Notification

General

Putin Says Russia Is Ready To Supply Gas Via Ukraine To Any Counter-Agent, But That's Impossible Due To Lawsuit From Kyiv; Ukraine Punishes Europe By Shutting Russian Gas Transit; Gas Prices In Europe Will Rise

WiMi Hologram Cloud Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIMI#NASDAQ">WIMI</a>) shares are <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/n42686949/wimi-develops-a-quantum-technology-based-random-access-memory-architecture" rel="noreferrer noopener">trading higher on Thursday.</a>
The firm has announced the development of a Quantum Technology-Based Random Access Memory Architecture, known as QRAM.
QRAM combines quantum logic gates such as the CNOT gate, V gate, and V+ gate to perform logical operations like AND, OR, NOT, and NOR within quantum systems, harnessing quantum properties like superposition and entanglement for enhanced computational efficiency.
Unlike traditional RAM, which operates sequentially, QRAM leverages quantum superposition to enable parallel data access, significantly speeding up operations.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/global/24/12/42686735/azerbaijan-airliner-crash-kills-38-weather-russia-under-scrutiny" rel="noreferrer noopener">Azerbaijan Airliner Crash Kills 38: Weather, Russia Under Scrutiny</a>
Quantum entanglement further improves efficiency by allowing multiple qubits to be correlated without direct communication, resulting in faster data transfer and processing. This design dramatically enhances computational performance, especially for large-scale tasks like molecular simulations and complex optimizations.
WiMi's QRAM architecture also integrates a quantum error correction mechanism, which ensures that qubit states remain stable and accurate during data read and write operations. This feature is crucial for maintaining reliability in quantum computing systems, where external disturbances can easily cause errors.
The QRAM system is highly compatible with quantum processing units, enabling smooth data transmission between memory and processors, which optimizes overall computational efficiency. With its ability to handle large datasets, QRAM is poised to advance quantum machine learning and quantum encryption applications, providing faster training and secure data transmission.
WiMi&#8217;s development of QRAM marks a significant step forward in quantum technology, setting the stage for a future where quantum computers play a crucial role in solving complex real-world problems.
Price Action: WIMI shares are trading higher by 13.3% to $1.27 at last check Thursday.
Also Read:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/24/12/42356227/spacexs-22488-satellite-expansion-challenged-over-elon-musks-russian-connections-and-environmental-risks" target="_blank" rel="noreferrer noopener">SpaceX's Satellite Expansion Challenged: Ukrainian-Americans Allege Elon Musk's Russian Ties And Environmental Risks In FCC Petition</a></li>
</ul>

Equities

Movers

WIMI

WiMi Develops Quantum Technology-Based QRAM Architecture, Shares Surge

Linkers Industries Shares Resume Trade

VistaGen Therapeutics GAAP EPS of -$0.35 beats by $0.06, revenue of $0.08M misses by $0.22M

Vistagen Therapeutics, Inc. (VTGN) Q1 2025 Earnings Call Transcript

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
VistaGen Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/vtgn-stock-quote/">VTGN</a>) just reported results for the first quarter of 2025.<ul><li>VistaGen Therapeutics reported earnings per share of -35 cents. This was above the analyst estimate for EPS of -40 cents.</li><li>The company reported revenue of $84,000.</li><li>This was 72% worse than the analyst estimate for revenue of $300,000.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/vtgn-stock-earnings-vistagen-therapeutics-for-q1-of-2025/">VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q1 2025</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q1 2025

In a report released yesterday, Jason McCarthy from Maxim Group reiterated a Buy rating on VistaGen Therapeutics (VTGN – Research Report), with a p...

Buy Rating Affirmed on VistaGen Therapeutics Amid Strong Financials and Promising Clinical Trials

Vistagen Could Run Up Ahead Of Phase 3 Results In Social Anxiety Disorder

Reports Q2 revenue $183,000, consensus $220,000. "We initiated our PALISADE-4 Phase 3 trial during our second quarter, achieving yet another signif...

Vistagen reports Q2 EPS (42c), consensus (39c)

VistaGen Therapeutics GAAP EPS of -$0.42 misses by $0.03, revenue of $0.18M beats by $0.15M

Analyst Jason McCarthy of Maxim Group maintained a Buy rating on VistaGen Therapeutics (VTGN – Research Report), retaining the price target of $12....

VistaGen Therapeutics' Promising Clinical Progress and Strong Financial Position Justify Buy Rating

Vistagen Therapeutics, Inc. (VTGN) Q2 2025 Earnings Call Transcript

An announcement from VistaGen Therapeutics ( ($VTGN) ) is now available. Vistagen Therapeutics is making strides in the neuroscience field, focusin...

VistaGen Therapeutics Advances Neurocircuitry Treatments

VTGN

Press Releases

Vistagen Awarded Mental Health America's Platinum Bell Seal for Workplace Mental Health for the Second Consecutive Year

Vistagen Broadens PH80 Global Intellectual Property Portfolio with New Patents for the Treatment of Migraine

Vistagen to Report Fiscal Year 2025 First Quarter Results and Host Corporate Update Conference Call on August 13, 2024

Vistagen Reports Fiscal Year 2025 First Quarter Financial Results and Corporate Update

Vistagen Initiates PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder

Vistagen, The Goldie Hawn Foundation, and MindUP Students to Ring Nasdaq Closing Bell on World Mental Health Day

Vistagen to Report Fiscal Year 2025 Second Quarter Results and Host Corporate Update Conference Call on November 7, 2024

Vistagen to Present at the 2024 Neuroscience Education Institute Congress

Vistagen Reports Fiscal Year 2025 Second Quarter Financial Results and Corporate Update

Comments

Vistagen Therapeutics

ニュース

最新ニュース Vistagen Therapeutics (NASDAQ:VTGN) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル